Over the holidays, the CDC informed Americans that Omicron had become the dominant COVID variant in the United States. A week before Christmas, headlines blared that Omicron had come to represent nearly three-quarters of new cases in the country. A week-and-a-half later the same experts announced a revision. A huge revision. Did we say 73 percent? We meant, um, 23 percent:
The CDC had previously reported that as of Dec. 18, 73% of new cases were linked to omicron. But on Tuesday, the agency revised those figures, slashing that estimate to 23% — a 50-point drop, suggesting that while the new variant was on the rise, it was not infecting people at the rate the CDC had projected...The most recent report shows that as of Dec. 25, 59% of all U.S. infections were caused by omicron. Meanwhile, delta accounted for 41% of cases during the same period.
So they said three-in-four COVID infections were Omicron in mid-December, then changed that number to one-in-four, then said that the real stat at Christmas was nearly 60 percent. Data guru Nate Silver reacted in a stunned tweet that read, in part: "Seriously WTF?!?!? I think we have to assume the CDC's method is crap and should be ignored going forward." This misfire was not merely confusing; it was actually harmful:
The continued incompetence is incredible
— AG (@AGHamilton29) December 29, 2021
Last week feds stopped shipping 2 monoclonal antibody treatments due to lower efficacy against Omicron bc of CDC estimate = 73% of new cases: https://t.co/gKdyhKHOQ1
Then CDC adjusted estimate to 22.5% 4 that weekhttps://t.co/fgXguJwSiV
The U.S. government says it has halted distribution of two of the three available COVID-19 monoclonal antibody treatments because they are not sufficiently effective against the omicron variant. The Office of the Assistant Secretary for Preparedness and Response, or ASPR, announced the pause in a statement Wednesday. The Food and Drug Administration released data showing that it is unlikely the therapeutics from Regeneron and Eli Lilly retain activity against omicron. However, a similar treatment developed by GlaxoSmithKline and Vir Biotechnology, called sotrovimab, does appear to retain activity against the variant, the FDA said. According to the latest data from the Centers for Disease Control and Prevention, omicron accounts for 73% of new cases in the U.S.
Recommended
That last sentence was accurate at the time, but the CDC's data was not. They halted distribution of highly successful COVID treatments because those treatments have been deemed ineffective against a variant whose prevalence they'd wildly overestimated. How many people stricken with Delta (over a certain stretch of time) were unable to receive monoclonal antibodies because CDC got their numbers wrong? CDC officials also made a major change on isolation guidance -- shifting the time frame from ten days to five. And also this:
LATEST: The newly updated CDC guidelines don't require testing at the end of isolation because PCR tests can stay positive for up to 12 weeks, CDC Director Dr. Rochelle Walensky tells @GMA. https://t.co/p6HUxeD4Go pic.twitter.com/TmVaF0eRcG
— ABC News (@ABC) December 29, 2021
Isolation times slashed in half, with no test requirement at the tail end. And what was this new advice based upon? And why did it arrive when it did, as opposed to earlier? Behold:
“It really had a lot to do with what we thought people would be able to tolerate,” CDC Director Walensky says on why the CDC shortened the isolation period from 10 days to 5 days if you’re asymptomatic. Our full interview: pic.twitter.com/rO7blPFiPj
— Kaitlan Collins (@kaitlancollins) December 29, 2021
Obviously, public sentiment will always play some role in shaping policy, but just flat-out admitting that the "science" has "a lot to do with" what bureaucrats believe people will accept is actually rather breathtaking. It's reminiscent of Dr. Fauci's little 'white lies' on masks and herd immunity levels. They think they're being extra clever, but they're actually diminishing credibility and eroding trust. Incoherence and backtracking only make things worse. So, naturally, let's throw in some incoherence:
5 days for adults, but 10 days for kids - the group with the lowest risk from COVID, but highest costs of being ‘out’. https://t.co/ATpVXzFTCt
— Joseph Allen (@j_g_allen) January 2, 2022
Various school districts and universities are taking advantage of the Omicron spike to justify new closures and remote "learning." More outrageous, active harm, which others are admirably resisting. And here's some apparent backtracking, for good measure:
Fauci signals that the CDC will soon revise its guidance about ending isolation 5 days after infection.
— Will Saletan (@saletan) January 2, 2022
Making a negative test part of the guidance is "now under consideration," he says, and "I think we're going to be hearing more about that in the next day or so from the CDC."
Critics are justifiably frustrated:
“PCR tests are not viable as can be positive for up to 12 weeks” “Antigen tests don’t correlate well with whether someone is still infectious” “etc etc
— AG (@AGHamilton29) January 2, 2022
*A bunch of people get mad*
Policy gets rewritten 2 weeks later.
Clearly purely based on science.
"Like a weathervane unfailingly twisting to whatever policy with whatever timing and reasoning makes *all* of its policies least trustworthy. It’s actually impressive," writes Mary Katharine Ham. Some people won't listen to experts no matter what, but others are willing to listen -- but trust can be lost, and in many cases, it has been lost. Rather than hang-wringing about the unwashed masses refusing to adhere to their advice,the advice-givers should look in the mirror. Finally, amid the many hair-on-fire headlines and fear-mongering about case counts (which even Fauci is at last beginning to downplay -- just as he's starting to lean into the important "of" vs. "with" distinction), I'll leave you with lots of very good news about Omicron:
While data is skewed by reduced holiday reporting, there’s increasing signs #Omicron wave in London may be peaking. The huge wave has occurred, so far, with only a small rise in hospital admissions requiring mechanical ventilation. New York City may be about 2 weeks behind London pic.twitter.com/WIqFkB16f9
— Scott Gottlieb, MD (@ScottGottliebMD) December 31, 2021
“More than half a dozen experiments made public in recent days all pointed to the same conclusion: Omicron is milder than Delta and other earlier versions of the virus.” https://t.co/dmy1yLEbXI
— Josh Kraushaar (@HotlineJosh) December 31, 2021
Breaking News: South Africa said health data suggested its Omicron peak had passed with no major spike in deaths, offering cautious hope to other countries. https://t.co/rCto7nPHg8
— The New York Times (@nytimes) December 30, 2021
Want to kick off 2022 w/ good news?
— Reuben Rodriguez (@ReubenR80027912) January 1, 2022
Here’s the last week of Dec ‘21 vs ‘20
Cases: +90%
Positivity: +43%
Deaths: -45%
CFR: -76% (1.26% vs 0.36)
In summary: we have double the cases & 1/4 of the deaths of last December...that’s as good an omen as possible https://t.co/Yegcr53Bq9
Join the conversation as a VIP Member